Clinical imaging studies in stroke patients found high matrix metallopeptidases-9 (MMP-9) blood levels to be associated with secondary brain damage in the hyper-acute and acute stage after an ischemic stroke (14, 15). This evidence concerns the gene MMP9 and ischemic stroke.